Statera Biopharma Inc. (STAB) at a glance

Statera Biopharma Inc. (STAB) is a micro-cap Healthcare company. It trades at $0, with a 0% profit margin and revenue growth of 183.5%. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Growth (92/100) and its weakest is Momentum (12/100). It carries above-market volatility, so expect larger swings.

Price
$0.00
Market cap
$7,141
P/E ratio
n/a
Dividend yield
None
Beta
191.91
52-week range
$0.00 to $0.00
Vestovix Score49/ 100How this works
Value
50
Growth
92
Income
40
Safety
20
Momentum
12